Regression of metastatic transitional cell carcinoma in response to tamoxifen

Journal of Urology

Volumn 165, Issue 5 I, 2001, Pages 1631-

  Dellagrammaticas, Demosthenes ^a   Bryden, A A Gordon ^a   Collins, Gerald N ^a  

^a STEPPING HILL HOSPITAL   (United Kingdom)

Author keywords

Bladder; Carcinoma, transitional cell; Neoplasm metastasis; Tamoxifen

Indexed keywords

TAMOXIFEN;

AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER REGRESSION; CASE REPORT; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0035043518     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66370-7     Document Type: Article

References (4)

1. Treatment of gynaecomastia with tamoxifen: A double-blind crossover study
2. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma
3. Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique
4. Tamoxifen enhances the chemosensitivity of bladder carcinoma cells